Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Multidrug resistance among gram-negative pathogens that caused healthcare-associated infections reported to the National Healthcare Safety Network, 2006-2008.

Kallen AJ, Hidron AI, Patel J, Srinivasan A.

Infect Control Hosp Epidemiol. 2010 May;31(5):528-31. doi: 10.1086/652152.

PMID:
20334552
2.
3.

Resistance in nonfermenting gram-negative bacteria: multidrug resistance to the maximum.

McGowan JE Jr.

Am J Med. 2006 Jun;119(6 Suppl 1):S29-36; discussion S62-70. Review.

PMID:
16735148
4.

Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria.

Li J, Nation RL, Milne RW, Turnidge JD, Coulthard K.

Int J Antimicrob Agents. 2005 Jan;25(1):11-25. Review.

PMID:
15620821
5.

Clinical and economic impact of common multidrug-resistant gram-negative bacilli.

Giske CG, Monnet DL, Cars O, Carmeli Y; ReAct-Action on Antibiotic Resistance.

Antimicrob Agents Chemother. 2008 Mar;52(3):813-21. Epub 2007 Dec 10. Review. No abstract available.

6.

Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches.

Karaiskos I, Giamarellou H.

Expert Opin Pharmacother. 2014 Jul;15(10):1351-70. doi: 10.1517/14656566.2014.914172. Epub 2014 Apr 28. Review.

7.

Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?

Falagas ME, Bliziotis IA.

Int J Antimicrob Agents. 2007 Jun;29(6):630-6. Epub 2007 Feb 16. Review.

PMID:
17306965
8.

Emerging resistant Gram-negative aerobic bacilli in hospital-acquired infections.

Kunz AN, Brook I.

Chemotherapy. 2010;56(6):492-500. doi: 10.1159/000321018. Epub 2010 Nov 24. Review.

PMID:
21099222
9.

New treatment options for infections caused by multiresistant strains of Pseudomonas aeruginosa and other nonfermenting gram-negative bacilli.

Sánchez A, Gattarello S, Rello J.

Semin Respir Crit Care Med. 2011 Apr;32(2):151-8. doi: 10.1055/s-0031-1275527. Epub 2011 Apr 19. Review.

PMID:
21506051
10.

Treatment of multidrug-resistant Gram-negative infections in children.

Hsu AJ, Tamma PD.

Clin Infect Dis. 2014 May;58(10):1439-48. doi: 10.1093/cid/ciu069. Epub 2014 Feb 5. Review.

11.

The role of gram-negative bacteria in healthcare-associated pneumonia.

Restrepo MI, Anzueto A.

Semin Respir Crit Care Med. 2009 Feb;30(1):61-6. doi: 10.1055/s-0028-1119810. Epub 2009 Feb 6. Review.

PMID:
19199188
12.

Bacteriocins active against multi-resistant gram negative bacteria implicated in nosocomial infections.

Ghodhbane H, Elaidi S, Sabatier JM, Achour S, Benhmida J, Regaya I.

Infect Disord Drug Targets. 2015;15(1):2-12. Review.

PMID:
24853876
13.

Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting.

Navon-Venezia S, Ben-Ami R, Carmeli Y.

Curr Opin Infect Dis. 2005 Aug;18(4):306-13. Review.

PMID:
15985826
14.

Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy.

Zavascki AP, Carvalhaes CG, Picão RC, Gales AC.

Expert Rev Anti Infect Ther. 2010 Jan;8(1):71-93. doi: 10.1586/eri.09.108. Review.

PMID:
20014903
15.

Antibiotic-resistant gram-negative bacterial infections in patients with cancer.

Perez F, Adachi J, Bonomo RA.

Clin Infect Dis. 2014 Nov 15;59 Suppl 5:S335-9. doi: 10.1093/cid/ciu612. Review.

16.

The threat of antibiotic resistance in Gram-negative pathogenic bacteria: beta-lactams in peril!

Thomson JM, Bonomo RA.

Curr Opin Microbiol. 2005 Oct;8(5):518-24. Review.

PMID:
16126451
17.

Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies.

Falagas ME, Kastoris AC, Karageorgopoulos DE, Rafailidis PI.

Int J Antimicrob Agents. 2009 Aug;34(2):111-20. doi: 10.1016/j.ijantimicag.2009.03.009. Epub 2009 Apr 28. Review.

PMID:
19403273
18.

An overview of antimicrobial susceptibility patterns for gram-negative bacteria from the National Antimicrobial Resistance Surveillance Thailand (NARST) program from 2000 to 2005.

Apisarnthanarak A, Buppunharun W, Tiengrim S, Sawanpanyalert P, Aswapokee N.

J Med Assoc Thai. 2009 Aug;92 Suppl 4:S91-4. Review.

PMID:
21298849
19.

Multiresistant Gram-negative infections: a global perspective.

Ho J, Tambyah PA, Paterson DL.

Curr Opin Infect Dis. 2010 Dec;23(6):546-53. doi: 10.1097/QCO.0b013e32833f0d3e. Review.

PMID:
20802331
20.

Treatment options for multidrug-resistant nonfermenters.

Briceño DF, Quinn JP, Villegas MV.

Expert Rev Anti Infect Ther. 2010 Mar;8(3):303-15. doi: 10.1586/eri.09.125. Review.

PMID:
20192684
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk